StockData
Renalytix plc logo

Renalytix plc (RNLXY) stock

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Renalytix total assets

Total assets on the balance sheet at the end of each period.

Renalytix's total assets was $4.79M at Sep 30, 2024. For fiscal 2024 it was $7.97M, down 74.0% from the year before. The highest annual figure on record is $78.58M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2024Jun 30, 2024$7.97M-74.0%
FY2023Jun 30, 2023$30.63M-38.8%
FY2022Jun 30, 2022$50.07M-36.3%
FY2021Jun 30, 2021$78.58M+276.3%
FY2020Jun 30, 2020$20.88M+115.3%
FY2019Jun 30, 2019$9.70M+8334.8%
FY2018Jun 30, 2018$115.00K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2025CQ3 2024Sep 30, 2024$4.79M-75.5%
Q4 FY2024CQ2 2024Jun 30, 2024$7.97M-74.0%
Q3 FY2024CQ1 2024Mar 31, 2024$8.77M-78.0%
Q2 FY2024CQ4 2023Dec 31, 2023$11.28M-63.2%
Q1 FY2024CQ3 2023Sep 30, 2023$19.54M-49.5%
Q4 FY2023CQ2 2023Jun 30, 2023$30.63M-38.8%
Q3 FY2023CQ1 2023Mar 31, 2023$39.80M-10.5%
Q2 FY2023CQ4 2022Dec 31, 2022$30.66M-43.6%
Q1 FY2023CQ3 2022Sep 30, 2022$38.71M-50.7%
Q4 FY2022CQ2 2022Jun 30, 2022$50.07M+139.7%
Q3 FY2022CQ1 2022Mar 31, 2022$44.47M+358.4%
Q2 FY2022CQ4 2021Dec 31, 2021$54.36M+47167.0%
Q4 FY2021CQ2 2021Jun 30, 2021$78.58M–
Q4 FY2020CQ2 2020Jun 30, 2020$20.88M–
Q4 FY2019CQ2 2019Jun 30, 2019$9.70M–
Q4 FY2018CQ2 2018Jun 30, 2018$115.00K–

More Renalytix figures

See a number that looks wrong?